A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment

PHASE3CompletedINTERVENTIONAL

Enrollment

387

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

December 16, 2022

Study Completion Date

March 28, 2023

Conditions

Postoperative Analgesia

Interventions

DRUG

HSK21542 Injection

1μg/kg/dose

DRUG

Tramadol hydrochloride

50mg/dose

DRUG

placebo

Trial Locations (1)

Union Hospital, Tongji Medical College, Huazhong U, Wuhan

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY